Related references
Note: Only part of the references are listed.Antibodies against polyethylene glycol in human blood: A literature review
Lu Hong et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)
Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?
Ronald R. Bowsher et al.
AAPS JOURNAL (2020)
Development and validation of a novel immunogenicity assay to detect anti-drug and anti-PEG antibodies simultaneously with high sensitivity
Nicoletta Bivi et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2020)
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Protein A/G-based enzyme-linked immunosorbent assay for detection of anti-Pythium insidiosum antibodies in human and animal subjects
Chalisa Jaturapaktrarak et al.
BMC RESEARCH NOTES (2020)
Structural basis of polyethylene glycol recognition by antibody
Cheng-Chung Lee et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Report on the AAPS Immunogenicity Guidance Forum
Heather Myler et al.
AAPS JOURNAL (2019)
Addressing soluble target interference in the development of a functional assay for the detection of neutralizing antibodies against a BCMA-CD3 bispecific antibody
Ying Wang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
Immunogenicity Associated with Botulinum Toxin Treatment
Steven Bellows et al.
TOXINS (2019)
A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum
Christopher Ehlinger et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
Harmonization and standardization of immunogenicity assessment of biotherapeutic products
Meenu Wadhwa et al.
BIOANALYSIS (2019)
Immunogenicity of Protein Pharmaceuticals
Robert Dingman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases
Umbreen Hafeez et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Immunogenicity of therapeutic protein products: current considerations for anti-drug antibody assay in Japan
Akiko Ishii-Watabe et al.
BIOANALYSIS (2018)
Monoclonal Antibodies: A Review
Surjit Singh et al.
CURRENT CLINICAL PHARMACOLOGY (2018)
Polyvalent immunoglobulin binding is an obstacle to accurate measurement of specific antibodies with ELISA despite inclusion of blocking agents
David A. Loeffler et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
A biotin-drug extraction and acid dissociation (BEAD) procedure to eliminate matrix and drug interference in a protein complex anti-drug antibody (ADA) isotype specific assay
Hongmei Niu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Development of an enzyme immunoassay for detection of antibodies against Coccidioides in dogs and other mammalian species
Nancy A. Chow et al.
PLOS ONE (2017)
An ELISA protocol to improve the accuracy and reliability of serological antibody assays
Takaki Waritani et al.
METHODSX (2017)
Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points
Viswanath Devanarayan et al.
AAPS JOURNAL (2017)
Evaluating and Reporting the Immunogenicity Impacts for Biological Products-a Clinical Pharmacology Perspective
Yow-Ming C. Wang et al.
AAPS JOURNAL (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Preventing further misuse of the ELISA technique and misinterpretation of serological antibody assay data
Kuniaki Terato et al.
VACCINE (2016)
Fc-Binding Ligands of Immunoglobulin G: An Overview of High Affinity Proteins and Peptides
Weonu Choe et al.
MATERIALS (2016)
Evaluation of Multiple Immunoassay Technology Platforms to Select the Anti-Drug Antibody Assay Exhibiting the Most Appropriate Drug and Target Tolerance
Justine Collet-Brose et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies
Michael A. Partridge et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Immunogenicity assessment of biotherapeutic products: An overview of assays and their utility
Meenu Wadhwa et al.
BIOLOGICALS (2015)
A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays
Jad Zoghbi et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Building better monoclonal antibody-based therapeutics
George J. Weiner
NATURE REVIEWS CANCER (2015)
Preventing intense false positive and negative reactions attributed to the principle,of ELISA to re-investigate antibody studies in autoimmune diseases
Kuniaki Terato et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Narendra Chirmule et al.
AAPS JOURNAL (2012)
Clinical Relevance of Botulinum Toxin Immunogenicity
Reiner Benecke
BIODRUGS (2012)
Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development
Alvydas Mikulskis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Monoclonal antibodies in cancer therapy: 25 years of progress
Robert K. Oldham et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
Gopi Shankar et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
An affinity capture elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug
James S. Bourdage et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products
AR Mire-Sluis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)